SEC Form 4 · accession 0001127602-16-059049
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard F Wallman
Director
Period of report
Jul 29, 2016
Accepted (ET)
Aug 1, 2016 · 4:00 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 29, 2016 | M | 7,740 | $40.27 | A | 24,190 | D | |
| Common Stock | Jul 29, 2016 | S | 7,740 | $88.00 | D | 16,450 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $40.27 | Jul 29, 2016 | M | 7,740 | D | May 11, 2012 | May 11, 2018 | Common Stock | 7,740 | 0 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.